Fees for Sanitation Inspections of Cruise Ships, 70078-70079 [05-22967]
Download as PDF
<![CDATA[
70078
Federal Register / Vol. 70, No. 223 / Monday, November 21, 2005 / Notices
retardation, lifespan-extension, and
organ procurement for transplantation.
Publications issued by the Council to
date include: Human Cloning and
Human Dignity: An Ethical Inquiry (July
2002); Beyond Therapy: Biotechnology
and the Pursuit of Happiness (October
2003); Being Human: Readings from the
President’s Council on Bioethics
(December 2003); Monitoring Stem Cell
Research (January 2004), Reproduction
and Responsibility: The Regulation of
New Biotechnologies (March 2004),
Alternative Sources of Human
Pluripotent Stem Cells: A White Paper
(May 2005), and Taking Care: Ethical
Caregiving in Our Aging Society
(September 2005).
DATES: The meeting will take place
Thursday, December 8, 2005, from 9
a.m. to 4:30 p.m. ET; and Friday,
December 9, 2005, from 8:30 a.m. to
12:30 p.m. ET.
ADDRESSES: City Center Hotel, 1143
New Hampshire Avenue, NW.,
Washington, DC 20037. Phone 202–775–
0800.
Agenda: The meeting agenda will be
posted at https://www.bioethics.gov.
Public Comments: The Council
encourages public input, either in
person or in writing. At this meeting,
interested members of the public may
address the Council, beginning at 11:30
a.m., on Friday, December 9. Comments
are limited to no more than five minutes
per speaker or organization. As a
courtesy, please inform Ms. Diane
Gianelli, Director of Communications,
in advance of your intention to make a
public statement, and give your name
and affiliation. To submit a written
statement, mail or e-mail it to Ms.
Gianelli at one of the addresses given
below.
Ms.
Diane Gianelli, Director of
Communications, The President’s
Council on Bioethics, Suite 700, 1801
Pennsylvania Avenue, Washington, DC
20006. Telephone: 202/296–4669. Email: info@bioethics.gov. Web site:
https://www.bioethics.gov.
FOR FURTHER INFORMATION CONTACT:
Dated: November 16, 2005.
Richard Roblin,
Acting Executive Director, The President’s
Council on Bioethics.
[FR Doc. 05–22990 Filed 11–18–05; 8:45 am]
BILLING CODE 4154–06–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Fees for Sanitation Inspections of
Cruise Ships
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice.
Average cost per inspection =
The average cost per inspection is
multiplied by a size/cost factor to
determine the fee for vessels in each
size category. The size/cost factor was
established in the proposed fee schedule
published in the Federal Register on
July 17, 1987, (52 FR 27060) and revised
in a schedule published in the Federal
Register on November 28, 1989, (54 FR
48942). The revised size/cost factor is
presented in Appendix A.
SUMMARY: This notice announces an
increase in the fees for vessel sanitation
inspections for the remainder of fiscal
year 2006 (January 1, 2006, through
September 30, 2006).
DATES: Effective January 1, 2006.
FOR FURTHER INFORMATION CONTACT:
David L. Forney, Chief, Vessel
Sanitation Program, National Center for
Environmental Health, Centers for
Disease Control and Prevention (CDC),
4770 Buford Highway, NE., Mailstop F–
23, Atlanta, Georgia 30341–3724,
telephone (770) 488–7333, E-mail:
Dforney@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose and Background
The fee schedule for sanitation
inspections of passenger cruise ships
inspected under the Vessel Sanitation
Program (VSP) was first published in
the Federal Register on November 24,
1987, (52 FR 45019), and CDC began
collecting fees on March 1, 1988. Since
1987, CDC has published the fee
schedule annually. The fees schedule
for FY 2006 was initially announced in
the Federal Register on September 7,
2005, with fees effective October 1,
2005. Because of a significant increase
in travel expenses and personnel costs,
VSP will be increasing inspection fees
effective January 1, 2006. This will be
the first increase in fees since FY 2002.
The formula used to determine the
fees is as follows:
Total cost of VSP
Weighted number of annual inspections
Fee
Applicability
The fee schedule (Appendix A) will
be effective January 1, 2006, through
September 30, 2006. If travel expenses
continue to increase, the fees may need
adjustment before September 30, 2006,
because travel constitutes a sizable
portion of VSP’s costs. If an adjustment
is necessary, a notice will be published
in the Federal Register 30 days before
the effective date.
The fees will apply to all passenger
cruise vessels for which inspections are
conducted as part of CDC’s VSP.
Dated: November 7, 2005.
Carlton Duncan,
Deputy Chief Operating Officer, Office of the
Director, Centers for Disease Control and
Prevention (CDC).
Appendix A
SIZE/COST FACTOR
GRT 1
Extra Small ..................................................................................................................................................
Small ............................................................................................................................................................
Medium ........................................................................................................................................................
Large ............................................................................................................................................................
Extra Large ..................................................................................................................................................
1 Gross
<3,001
3,001–15,000
15,001–30,000
30,001–60,000
>60,000
register tonnage in cubic feet, as shown in Lloyd’s Register of Shipping.
VerDate Aug<31>2005
15:51 Nov 18, 2005
Jkt 208001
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
E:\FR\FM\21NON1.SGM
21NON1
Average cost
($U.S.) per GRT
0.25
0.50
1.00
1.50
2.00
EN21NO05.079</MATH>
Vessel size
Federal Register / Vol. 70, No. 223 / Monday, November 21, 2005 / Notices
70079
FEE SCHEDULE JANUARY 1, 2006–SEPTEMBER 30, 2006
Vessel size
GRT 1
Extra Small ..................................................................................................................................................
Small ............................................................................................................................................................
Medium ........................................................................................................................................................
Large ............................................................................................................................................................
Extra Large ..................................................................................................................................................
1 Gross
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Notice of Approval of Supplemental
New Animal Drug Application;
Ivermectin and Praziquantel Paste
Food and Drug Administration,
HHS.
ACTION:
<3,001
3,001–15,000
15,001–30,000
30,001–60,000
>60,000
1,300
2,600
5,200
7,800
10,400
register tonnage in cubic feet, as shown in Lloyd’s Register of Shipping.
Inspections and reinspections involve the
same procedure, require the same amount of
time, and are therefore charged at the same
rate.
[FR Doc. 05–22967 Filed 11–18–05; 8:45 am]
AGENCY:
Fee
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is providing
notice that it has approved a
supplemental new animal drug
application (NADA) filed by Merial, Ltd.
The NADA provides for oral use of an
ivermectin and praziquantel paste as an
over-the-counter product for the
treatment and control of various
parasitic conditions of horses. This
supplemental NADA reduces the
minimum age for administration from 5
months to 2 months of age.
FOR FURTHER INFORMATION CONTACT:
Melanie R. Berson, Center for Veterinary
Medicine (HFV–110), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301–827–7543, email: melanie.berson@fda.gov.
SUPPLEMENTARY INFORMATION: Merial,
Ltd., 3239 Satellite Blvd., bldg. 500,
Duluth, GA 30096–4640, filed a
supplement to NADA 141–214 for
ZIMECTERIN GOLD (ivermectin 1.55%/
praziquantel 7.75%) Paste, an over-thecounter product used for the oral
treatment and control of various
parasitic conditions of horses. This
supplemental NADA reduces the
minimum age for administration from 5
months to 2 months of age. In
accordance with section 512(i) of the
Federal Food, Drug, and Cosmetic Act
(the act) (21 U.S.C. 360b(i)) and part 514
(21 CFR part 514) in §§ 514.105(a) and
514.106(a), the Center for Veterinary
Medicine is providing notice that this
VerDate Aug<31>2005
15:51 Nov 18, 2005
Jkt 208001
supplemental NADA is approved as of
October 28, 2005. The basis of approval
is discussed in the freedom of
information summary.
In accordance with the freedom of
information provisions of 21 CFR part
20 and § 514.11(e)(2)(ii), a summary of
safety and effectiveness data and
information submitted to support
approval of this application may be seen
in the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852, between 9
a.m. and 4 p.m., Monday through
Friday.
FDA has determined under 21 CFR
25.33(d)(1) that this action is of a type
that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
Dated: November 7, 2005.
Steven D. Vaughn,
Director, Office of New Animal Drug
Evaluation, Center for Veterinary Medicine.
[FR Doc. 05–22941 Filed 11–18–05; 8:45 am]
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel, Gene Therapy
Clinical Trial.
Date: November 21, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Gateway Hotel Los Angeles
Airport, 6101 W Century Blvd., Los Angeles,
CA 90045.
Contact Person: Samuel Rawlings, PhD,
Chief, Scientific Review Branch, Division of
Extramural Research, National Eye Institute,
5635 Fishers Lane, Suite 1300, MSC 9300,
Bethesda, MD 20892–9300, 301–451–2020.
(Catalogue of Federal Domestic
Assistance Program No. 93.867, Vision
Research, National Institutes of Health,
HHS)
Dated: November 14, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–22932 Filed 11–18–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4160–01–S
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NHLBI.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual grant
applications conducted by the National
Heart, Lung, and Blood Institute,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Name of Committee: Board of Scientific
Counselors, NHLBI.
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 70, Number 223 (Monday, November 21, 2005)]
[Notices]
[Pages 70078-70079]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-22967]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Fees for Sanitation Inspections of Cruise Ships
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces an increase in the fees for vessel
sanitation inspections for the remainder of fiscal year 2006 (January
1, 2006, through September 30, 2006).
DATES: Effective January 1, 2006.
FOR FURTHER INFORMATION CONTACT: David L. Forney, Chief, Vessel
Sanitation Program, National Center for Environmental Health, Centers
for Disease Control and Prevention (CDC), 4770 Buford Highway, NE.,
Mailstop F-23, Atlanta, Georgia 30341-3724, telephone (770) 488-7333,
E-mail: Dforney@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose and Background
The fee schedule for sanitation inspections of passenger cruise
ships inspected under the Vessel Sanitation Program (VSP) was first
published in the Federal Register on November 24, 1987, (52 FR 45019),
and CDC began collecting fees on March 1, 1988. Since 1987, CDC has
published the fee schedule annually. The fees schedule for FY 2006 was
initially announced in the Federal Register on September 7, 2005, with
fees effective October 1, 2005. Because of a significant increase in
travel expenses and personnel costs, VSP will be increasing inspection
fees effective January 1, 2006. This will be the first increase in fees
since FY 2002.
The formula used to determine the fees is as follows:
[GRAPHIC] [TIFF OMITTED] TN21NO05.079
The average cost per inspection is multiplied by a size/cost factor
to determine the fee for vessels in each size category. The size/cost
factor was established in the proposed fee schedule published in the
Federal Register on July 17, 1987, (52 FR 27060) and revised in a
schedule published in the Federal Register on November 28, 1989, (54 FR
48942). The revised size/cost factor is presented in Appendix A.
Fee
The fee schedule (Appendix A) will be effective January 1, 2006,
through September 30, 2006. If travel expenses continue to increase,
the fees may need adjustment before September 30, 2006, because travel
constitutes a sizable portion of VSP's costs. If an adjustment is
necessary, a notice will be published in the Federal Register 30 days
before the effective date.
Applicability
The fees will apply to all passenger cruise vessels for which
inspections are conducted as part of CDC's VSP.
Dated: November 7, 2005.
Carlton Duncan,
Deputy Chief Operating Officer, Office of the Director, Centers for
Disease Control and Prevention (CDC).
Appendix A
Size/Cost Factor
------------------------------------------------------------------------
Average cost
Vessel size GRT 1 ($U.S.) per GRT
------------------------------------------------------------------------
Extra Small....................... <3,001 0.25
Small............................. 3,001-15,000 0.50
Medium............................ 15,001-30,000 1.00
Large............................. 30,001-60,000 1.50
Extra Large....................... >60,000 2.00
------------------------------------------------------------------------
1 Gross register tonnage in cubic feet, as shown in Lloyd's Register of
Shipping.
[[Page 70079]]
Fee Schedule January 1, 2006-September 30, 2006
------------------------------------------------------------------------
Vessel size GRT 1 Fee
------------------------------------------------------------------------
Extra Small....................... <3,001 1,300
Small............................. 3,001-15,000 2,600
Medium............................ 15,001-30,000 5,200
Large............................. 30,001-60,000 7,800
Extra Large....................... >60,000 10,400
------------------------------------------------------------------------
1 Gross register tonnage in cubic feet, as shown in Lloyd's Register of
Shipping.
Inspections and reinspections involve the same procedure,
require the same amount of time, and are therefore charged at the
same rate.
[FR Doc. 05-22967 Filed 11-18-05; 8:45 am]
BILLING CODE 4163-18-P
